Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience

Background Plexiform neurofibromas (PN) are the most frequent tumors associated with Neurofibromatosis type 1 (NF-1). PN can cause significant complications, including pain, functional impairment, and disfigurement. There is no efficient medical treatment and, surgical resection of large PN is frequ...

ver descrição completa

Detalhes bibliográficos
Autor principal: Espirito Santo, Vera (author)
Outros Autores: Passos, Joao (author), Nzwalo, Hipólito (author), Carvalho, Ines (author), Santos, Filipa (author), Martins, Carmo (author), Salgado, Lucilia (author), Silva, Conceicao e (author), Vinhais, Sofia (author), Vilares, Miguel (author), Salgado, Duarte (author), Nunes, Sofia (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Selumetinib
Plexiform neurofibromas
Neurofibromatosis
Treatment
Oncology; Neurosciences & Neurology
Texto completo:http://hdl.handle.net/10400.1/16563
País:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/16563

Texto Completo

http://hdl.handle.net/10400.1/16563

Registos relacionados